The medium-sized biopharma is showing off new results from dordaviprone and Zepzelca, both of which were acquired through ...

Yahoo Finance host Brad Smith tracks today's top moving stocks and biggest market stories in this Market Minute, including ...

Zilliz, creator of the leading open-source vector database Milvus, today announced that Milvus has achieved 35,000 stars on GitHub, establishing it as the most popular vector database platform ...

CureDuchenne is investing $1 million in Entos Pharmaceuticals to support the development of a new DMD gene therapy.

The report shows that CDNetworks' security platform intercepted 887.4 billion web attacks targeting applications and APIs in ...

Fintel reports that on May 28, 2025, Leerink Partners downgraded their outlook for Rocket Pharmaceuticals (NasdaqGM:RCKT) ...

T therapies is an expensive business. The fundamental problem is that CAR-T production is not a good fit for centralized manufacturing.

FDA places clinical hold of RP-A501 for the treatment of patients with Danon disease due to a patient death. Click here to ...

Sami Corwin, an analyst at William Blair, maintained his Outperform rating on Rocket Pharmaceuticals Inc. (NASDAQ:RCKT) on ...

Dengue Vaccines Market Projected to Grow from USD 90 Million in 2025 to Nearly USD 200 Million by 2035The global Dengue Vaccines Market is expected to be reach USD 90.0 million in 2025 and is likely ...

Fintel reports that on May 27, 2025, Needham downgraded their outlook for Rocket Pharmaceuticals (NasdaqGM:RCKT) from Buy to ...

Blood vessels are like big-city highways; full of curves, branches, merges, and congestion. Yet for years, lab models ...